Blend Labs, Inc. (NYSE:BLND) Receives Consensus Recommendation of "Hold" from Brokerages

Key Points

• Analyst consensus: "Hold" — Seven firms rate BLND a consensus "Hold" (1 sell, 2 hold, 4 buy) with a 1‑year average price target of $4.13.
• Recent analyst cuts and insider selling — UBS, Wells Fargo and Citizens JMP lowered targets in March and Weiss reiterated a sell, while insider Brian Kneafsey sold 25,000 shares (part of 33,125 shares sold by insiders in the past 90 days) and insiders own 35.52% of the stock.
• Market and ownership snapshot — BLND opened at $2.00 with a $512.9M market cap, a negative P/E (-19.95), a 12‑month range of $1.44–$4.49, 50‑day/200‑day SMAs of $1.84/$2.76, and institutional investors hold 52.56%.

Shares of Blend Labs, Inc. (NYSE:BLND - Get Free Report) have been given a consensus recommendation of "Hold" by the seven research firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $4.1333.

BLND has been the topic of several recent research reports. Weiss Ratings reiterated a "sell (d-)" rating on shares of Blend Labs in a report on Wednesday, January 21st. UBS Group reduced their price target on shares of Blend Labs from $3.00 to $2.00 and set a "neutral" rating for the company in a report on Wednesday, March 11th. Wells Fargo & Company lowered their price target on shares of Blend Labs from $5.00 to $4.00 and set an "overweight" rating for the company in a research report on Wednesday, March 11th. Finally, Citizens Jmp dropped their price objective on shares of Blend Labs from $7.00 to $5.00 and set a "market outperform" rating on the stock in a research note on Wednesday, March 11th.

Blend Labs Trading Down 0.2%

BLND opened at $2.00 on Friday. The company has a market capitalization of $512.93 million, a price-to-earnings ratio of -19.95 and a beta of 1.22. Blend Labs has a 12-month low of $1.44 and a 12-month high of $4.49. The business's fifty day simple moving average is $1.84 and its 200-day simple moving average is $2.76.

Insiders Place Their Bets

In other Blend Labs news, insider Brian Kneafsey sold 25,000 shares of the stock in a transaction on Thursday, January 15th. The stock was sold at an average price of $3.06, for a total transaction of $76,500.00. Following the sale, the insider owned 649,824 shares of the company's stock, valued at approximately $1,988,461.44. This trade represents a 3.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders sold a total of 33,125 shares of company stock worth $93,169 in the last ninety days. 35.52% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Blend Labs

A number of institutional investors have recently added to or reduced their stakes in BLND. Rice Hall James & Associates LLC purchased a new stake in shares of Blend Labs during the third quarter valued at about $3,043,000. Royce & Associates LP grew its position in shares of Blend Labs by 73.9% in the 3rd quarter. Royce & Associates LP now owns 1,671,240 shares of the company's stock worth $6,100,000 after buying an additional 709,989 shares during the last quarter. Tudor Investment Corp ET AL raised its stake in shares of Blend Labs by 81.0% during the 3rd quarter. Tudor Investment Corp ET AL now owns 1,300,087 shares of the company's stock worth $4,745,000 after acquiring an additional 581,622 shares in the last quarter. ShawSpring Partners LLC raised its stake in shares of Blend Labs by 10.4% during the 3rd quarter. ShawSpring Partners LLC now owns 9,840,605 shares of the company's stock worth $35,918,000 after acquiring an additional 929,566 shares in the last quarter. Finally, Mirabella Financial Services LLP lifted its position in Blend Labs by 64.5% during the third quarter. Mirabella Financial Services LLP now owns 2,643,777 shares of the company's stock valued at $9,650,000 after acquiring an additional 1,036,777 shares during the last quarter. Institutional investors own 52.56% of the company's stock.

Blend Labs Company Profile

Blend Labs, Inc operates as a financial technology company that offers a digital consumer banking platform designed to simplify and automate the lending and account opening processes for banks and credit unions. Its cloud-native software enables financial institutions to deliver a more seamless customer experience by consolidating multiple steps—such as application intake, identity verification, document collection and underwriting—into a unified digital workflow. Blend's platform is built to integrate with existing core banking systems and third-party data providers, allowing clients to accelerate loan origination and deposit account opening while maintaining compliance and security standards.

The company's product suite includes solutions for mortgage origination, home equity lending, consumer personal lending and deposit account opening.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.